NanoGroup S.A. (NNG.WA)

PLN 2.37

(-1.25%)

Revenue Summary of NanoGroup S.A.

  • NanoGroup S.A.'s latest annual revenue in 2023 was 2019.00 PLN , down -98.55% from previous year.
  • NanoGroup S.A.'s latest quarterly revenue in 2024 Q2 was - PLN , down -100.0% from previous quarter.
  • NanoGroup S.A. reported a annual revenue of 139.54 Thousand PLN in annual revenue 2022, down -71.66% from previous year.
  • NanoGroup S.A. reported a annual revenue of 492.49 Thousand PLN in annual revenue 2021, down -28.37% from previous year.
  • NanoGroup S.A. reported a quarterly revenue of 2000.00 PLN for 2024 Q1, up 128.65% from previous quarter.
  • NanoGroup S.A. reported a quarterly revenue of 6000.00 PLN for 2023 Q3, up 123.08% from previous quarter.

Annual Revenue Chart of NanoGroup S.A. (2023 - 2015)

Historical Annual Revenue of NanoGroup S.A. (2023 - 2015)

Year Revenue Revenue Growth
2023 2019.00 PLN -98.55%
2022 139.54 Thousand PLN -71.66%
2021 492.49 Thousand PLN -28.37%
2020 687.5 Thousand PLN 95.41%
2019 351.83 Thousand PLN 219.01%
2018 110.28 Thousand PLN 170.33%
2017 40.79 Thousand PLN 0.0%
2016 - PLN -100.0%
2015 7403.00 PLN 0.0%

Peer Revenue Comparison of NanoGroup S.A.

Name Revenue Revenue Difference
Bioceltix S.A. - PLN -Infinity%
BIOTON S.A. 181.63 Million PLN 99.999%
Captor Therapeutics Spolka Akcyjna 13.2 Million PLN 99.985%
Mabion S.A. 151.67 Million PLN 99.999%
Molecure S.A. 100.00 PLN -1919.0%
Pharmena S.A. 9.83 Million PLN 99.979%
Poltreg S.A. 1.39 Million PLN 99.856%
Pure Biologics Spólka Akcyjna 95 Thousand PLN 97.875%
Ryvu Therapeutics S.A. 46.86 Million PLN 99.996%
Synthaverse S.A. 58.6 Million PLN 99.997%
Urteste S.A. - PLN -Infinity%